MAJOR — Use With Caution
FDA-documented interaction. Paroxetine is the strongest CYP2D6 inhibitor among SSRIs. Clinical studies suggest increased breast cancer recurrence risk. Avoid this combination.
Evidence level: STRONG
Paroxetine (Paxil) is the worst antidepressant to combine with tamoxifen because it is the strongest blocker of the enzyme needed to activate tamoxifen. Studies suggest this combination may increase the risk of breast cancer returning.
Paroxetine is the most potent CYP2D6 inhibitor among SSRIs. Blocks conversion of tamoxifen to active endoxifen. Studies show significantly reduced endoxifen levels and potentially increased breast cancer mortality. FDA tamoxifen label warns.
Do not take Paxil with tamoxifen. Ask your oncologist for an antidepressant that does not block CYP2D6. Switching is important for your cancer treatment to work properly.
Take Paroxetine at the same time each day — morning is most common to avoid sleep disruption. Tamoxifen follows its prescribed schedule. SSRIs have a long half-life, so consistency matters more than the exact hour.
Higher risk for: elderly, those on multiple serotonergic drugs, people with liver impairment, CYP2D6 poor metabolizers, recent dose changes, or concurrent use of MAOIs or triptans.
No immediate symptoms — the concern is reduced long-term anticancer protection. Depression symptoms may also need management during the switch.
Ask your oncologist to coordinate with your psychiatrist. Switch to venlafaxine, citalopram, or escitalopram. Do not abruptly stop paroxetine (it requires gradual tapering).
Discuss this combination with your prescriber. They may adjust timing, dosing, or switch to an alternative with fewer interaction risks. Never stop an antidepressant abruptly — taper under medical guidance.
Paroxetine (Paxil) is the worst antidepressant to combine with tamoxifen because it is the strongest blocker of the enzyme needed to activate tamoxifen. Studies suggest this combination may increase the risk of breast cancer returning.
Take Paroxetine at the same time each day — morning is most common to avoid sleep disruption. Tamoxifen follows its prescribed schedule. SSRIs have a long half-life, so consistency matters more than the exact hour.
No immediate symptoms — the concern is reduced long-term anticancer protection. Depression symptoms may also need management during the switch.
Discuss this combination with your prescriber. They may adjust timing, dosing, or switch to an alternative with fewer interaction risks. Never stop an antidepressant abruptly — taper under medical guidance.
Ask your oncologist to coordinate with your psychiatrist. Switch to venlafaxine, citalopram, or escitalopram. Do not abruptly stop paroxetine (it requires gradual tapering).
Or browse the full interaction database (121,000+ pairs).